Delivery Order SPE2DB20D2014-SPE2DB25FC11R
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Lamotrigine ER 200 mg tablets in 30-count quantities. This contract, valued at $1,133.76, represents a firm fixed-price delivery order with an ultimate completion date of September 5, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lamotrigine ER 300 mg tablets in quantities of 30 units. This contract is valued at $1,704.06 with a firm fixed price structure and a completion date of August 26, 2025. The order represents a non-competitive, non-set-aside delivery under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,119.28 to AmerisourceBergen Drug Corp for Lamotrigine ER 300 mg tablets (30-count) on September 8, 2025, with completion scheduled for September 9, 2025. This firm fixed-price, competitively awarded delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is executed under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,323.38 to AmerisourceBergen Drug Corp for Lamotrigine ER 200 mg tablets (30-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. Lamotrigine is a generic anticonvulsant and mood-stabilizing medication commonly used in military...
- The Defense Logistics Agency awarded a delivery order valued at $4,824.31 to AmerisourceBergen Drug Corp for Lamotrigine ER 50 mg tablets (30-count) on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Lamotrigine is a neurological medication commonly used for seizure management and bipolar...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Lamotrigine ER 200 mg tablets in quantities of 30 units, with a ceiling value of $1,297.59 and an ultimate completion date of September 29, 2025. This non-competitive, firm fixed-price delivery order will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Lamotrigine is a neurological medication commonly used to treat seizure...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Lamotrigine ER 25 mg tablets in quantities of 30, with a ceiling value of $1,517.04. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,336.23 to AmerisourceBergen Drug Corp for Lamotrigine ER 300 mg tablets (30-count supply) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Lamotrigine is a neurological medication commonly used to treat epilepsy and bipolar...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamotrigine ER 250 mg tablets (30-count) with a ceiling value of $1,343.58 under a firm fixed-price contract type. The award was made on July 21, 2025, with an ultimate completion date of July 22, 2025, and represents a non-set-aside, competitively awarded transaction. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamotrigine ER 200 mg tablets (30-count units) on August 26, 2025, with a ceiling value of $1,004.61. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The ultimate completion date for this delivery order is August 27,...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC11RDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Lamotrigine ER 100 mg tablets in quantities of 30 units, with a ceiling value of $1,163.95. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 4, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating open competition among qualified vendors. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which holds a $999,999,999.00 potential value through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical commodities to support military healthcare systems and other government health programs. The lamotrigine supply fulfills ongoing pharmaceutical requirements within the broader medical supply chain managed by the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/3/25 |